National Academies Press: OpenBook
« Previous: A References
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×

B

Acronyms and Abbreviations

ASPR Office of the Assistant Secretary for Preparedness and Response
   
BARDA Biomedical Advanced Research and Development Authority
BIO Biotechnology Industry Organization
BLA biologics license application
   
CBRN chemical, biological, radiological, and nuclear
CDC Centers for Disease Control and Prevention
CIDRAP Center for Infectious Disease Research and Policy
CMC chemistry, manufacturing, and controls
CPTR Critical Path to TB Drug Regimens
   
DMID Division of Microbiology and Infectious Diseases (NIAID)
DoD Department of Defense
DST drug susceptibility testing
   
EFPIA European Federation of Pharmaceutical Industries and Associations
EMA European Medicines Agency
EU European Union
EUA emergency use authorization (FDA)
EVD Ebola virus disease
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
FDA Food and Drug Administration
FRMM Flu Risk Management Meeting
FSG Foundation Strategy Group
   
GSK GlaxoSmithKline
   
HHS Department of Health and Human Services
   
IND investigational new drug application
IOM Institute of Medicine
IRAT Influenza Risk Assessment Tool
   
MCM medical countermeasure
MERS Middle East respiratory syndrome
MERS-CoV Middle East respiratory syndrome coronavirus
   
NGDS Next Generation Diagnostics System
NIAID National Institute of Allergy and Infectious Diseases
NIH National Institutes of Health
NPV net present value
   
OTA Other Transactions Authority
   
PCAST President’s Council of Advisors on Science and Technology
PHEMCE Public Health Emergency Medical Countermeasures Enterprise
PMO phosphorodiamidate morpholino oligomer (Sarepta Platform)
   
qPCR quantitative reverse transcriptase polymerase chain reaction
   
rVSV-ZEBOV-GP recombinant vesicular stomatitis virus-based vaccine for the Zaire ebolavirus expressing EBOV glycoprotein (Merck Ebola Vaccine candidate)
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
SARS severe acute respiratory syndrome
SNS Strategic National Stockpile
   
TB tuberculosis
   
USAID U.S. Agency for International Development
USAMRID U.S. Army Medical Research Institute of Infectious Diseases
   
VHFC Viral Hemorrhagic Fever Consortium
   
WHO World Health Organization
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×

This page intentionally left blank.

Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
Page 109
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
Page 110
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
Page 111
Suggested Citation:"B Acronyms and Abbreviations." National Academies of Sciences, Engineering, and Medicine. 2016. Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21809.
×
Page 112
Next: C Statement of Task »
Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary Get This Book
×
Buy Paperback | $50.00 Buy Ebook | $39.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States has been extremely challenging. Interest and momentum peak during a crisis and wane between events, and there is little interest in disease threats outside the United States until they impact people stateside.

On March 26 and 27, 2015, the Institute of Medicine convened a workshop in Washington, DC to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. Public- and private-sector stakeholders examined recent efforts to prepare for and respond to outbreaks of Ebola Virus Disease, pandemic influenza, and coronaviruses from policy, budget, and operational standpoints. Participants discussed the need for rapid access to MCM to ensure national security and considered strategies and business models that could enhance stakeholder interest and investment in sustainable response capabilities. This report summarizes the presentations and discussions from this workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!